Dr. Tedros Adhanom Ghebreyesus declares the end of the COVID-19 pandemic, highlighting global vaccination efforts and future ...

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

Congresswoman Elise Stefanik (R-NY) on Thursday celebrated the passage of legislation that includes $250 million in federal funding for a partnership between the Defense Advanced Research Projects Ag ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Q1 2025 Earnings Call Transcript May 1, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-2.52, expectations ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...

The Cambridge-based biotech company has been trying to reduce operating expenses as it burns cash on its large pipeline.